Skip to search.
 Dow Up 0.50% Nasdaq Down 0.12%

Celgene Corporation (CELG)

-NasdaqGS

77.52 0.00(0.00%) 4:00PM EDT|After Hours: 77.52 0.00 (0.00%) 4:59PM EDT - Nasdaq Real Time Price

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2011Dec 31, 2010Dec 31, 2009
Total Revenue 4,842,070   3,625,745   2,689,893  
Cost of Revenue425,859  306,521  216,289  
Gross Profit 4,416,211   3,319,224   2,473,604  
Operating Expenses
Research Development1,600,264  1,128,495  794,848  
Selling General and Administrative1,083,968  997,863  753,827  
Non Recurring -   -   -  
Others289,226  203,231  83,403  
Total Operating Expenses -   -   -  
Operating Income or Loss 1,442,753   989,635   841,526  
Income from Continuing Operations
Total Other Income/Expenses Net22,310  37,537  137,246  
Earnings Before Interest And Taxes1,462,259  1,025,244  977,669  
Interest Expense42,737  12,634  1,966  
Income Before Tax1,419,522  1,012,610  975,703  
Income Tax Expense102,066  132,418  198,956  
Minority Interest694  320   -  
Net Income From Continuing Ops1,315,346  878,584  775,644  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,318,150   880,512   776,747  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,318,150   880,512   776,747  

Currency in USD.